| Firm |
Coverage Analyst |
|
Cantor Fitzgerald
|
Eric Schmidt
|
|
Capital One Securities, Inc.
|
Naureen Quibria
|
|
Guggenheim
|
Michael Schmidt
|
|
HC Wainwright & Co.
|
Rob Burns
|
|
J.P. Morgan
|
Brian Cheng
|
|
Jefferies
|
Kelly Shi
|
|
RBC Capital Markets
|
Greg Renza
|
|
Stephens
|
Sudan Loganathan
|
Footnote: ADC Therapeutics is followed by the analysts listed above. Please note that any
opinions, estimates or forecasts regarding the performance of ADC Therapeutics made by these
analysts are theirs alone and do not represent opinions, forecasts or predictions of ADC
Therapeutics or its management. ADC Therapeutics does not by its reference above or distribution
imply its endorsement of or concurrence with such information, conclusions or recommendations.